H.T. Edzes

Clinical Phase I and Pharmacology Study of Gemcitabine (2', 2'-Difluorodeoxycytidine) Administered in a Two-Weekly Schedule

G. Peters, J. Vermorken, P. Noordhuis, 2007, Journal of chemotherapy.